Cystatin C, renal disease, amyloidosis and antibiotics
31 – 40 of 129
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
Cystatin C is Indispensable for Evaluation of Kidney Disease
(
- Contribution to journal › Scientific review
- 2016
-
Mark
Shrunken Pore Syndrome is associated with a sharp rise in mortality in patients undergoing elective coronary artery bypass grafting.
(
- Contribution to journal › Article
- 2015
-
Mark
Reduction in glomerular pore size is not restricted to pregnant women. Evidence for a new syndrome: 'Shrunken pore syndrome'.
(
- Contribution to journal › Article
- 2014
-
Mark
Generation of a New Cystatin C-Based Estimating Equation for Glomerular Filtration Rate by Use of 7 Assays Standardized to the International Calibrator.
(
- Contribution to journal › Article
- 2013
-
Mark
Stabilization, Characterization and Selective Removal of Cystatin C Amyloid Oligomers.
(
- Contribution to journal › Article
- 2003
-
Mark
New antimicrobial cystatin C-based peptide active against gram-positive bacterial pathogens, including methicillin-resistant Staphylococcus aureus and multiresistant coagulase-negative staphylococci
2003) In APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 111(11). p.1004-1010(
- Contribution to journal › Article
- 2001
-
Mark
The cerebral hemorrhage-producing cystatin C variant (L68Q) in extracellular fluids
(
- Contribution to journal › Article
- 1999
-
Mark
Cystatin C deficiency in human atherosclerosis and aortic aneurysms
(
- Contribution to journal › Article
- 1998
-
Mark
Affinity screening for weak monoclonal antibodies
(
- Contribution to journal › Article
-
Mark
The increase of plasma homocysteine concentrations with age is partly due to the deterioration of renal function as determined by plasma cystatin C
(
- Contribution to journal › Article